Kohl’s Says Is Seeing ‘a softening in consumer spending and now expects sales to be down high-single digits for Q2, as compared to our prior expectations of down low-single digits relative to last year.’

The Company is providing the following update on second quarter business trends related to macroeconomic issues. As inflationary pressures on the consumer continue, the Company is seeing a softening in consumer

The Company is providing the following update on second quarter business trends related to macroeconomic issues. As inflationary pressures on the consumer continue, the Company is seeing a softening in consumer spending and now expects sales to be down high-single digits for Q2, as compared to our prior expectations of down low-single digits relative to last year. The Company is taking actions to navigate this environment and will share more when it releases Q2 earnings on August 18.

Total
0
Shares
Related Posts
Read More

MapKure, BeiGene And SpringWorks Present Clinical Data On BGB-3245, A Selective Next-Generation B-RAF Inhibitor, In Adult Patients With Advanced Or Refractory Solid Tumors At The American Association For Cancer Research Annual Meeting 2023

MapKure, LLC, BeiGene, Ltd. (NASDAQ:BGNE, HKEX: 06160, SSE: 688235)))), and SpringWorks Therapeutics, Inc. (NASDAQ:SWTX), today announced that they will present updated clinical data from the Phase 1a/1b study of

BGNE